These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21524402)

  • 21. West Nile virus neuroinvasive disease.
    Davis LE; DeBiasi R; Goade DE; Haaland KY; Harrington JA; Harnar JB; Pergam SA; King MK; DeMasters BK; Tyler KL
    Ann Neurol; 2006 Sep; 60(3):286-300. PubMed ID: 16983682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of West Nile virus infection in solid organ transplant recipients.
    Freifeld AG; Meza J; Schweitzer B; Shafer L; Kalil AC; Sambol AR
    Transpl Infect Dis; 2010 Apr; 12(2):120-6. PubMed ID: 19874565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of effective therapies against West Nile virus infection.
    Diamond MS
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):931-44. PubMed ID: 16307506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunoglobulin as a treatment for West Nile virus infection.
    Agrawal AG; Petersen LR
    J Infect Dis; 2003 Jul; 188(1):1-4. PubMed ID: 12825164
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibodies against the West Nile virus and other arthropod-transmitted viruses in the Ebro Delta region].
    Lozano A; Filipe AR
    Rev Esp Salud Publica; 1998; 72(3):245-50. PubMed ID: 9810831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
    Shimoni Z; Niven MJ; Pitlick S; Bulvik S
    Emerg Infect Dis; 2001; 7(4):759. PubMed ID: 11585547
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of RNA interference to prevent lethal murine west nile virus infection.
    Bai F; Wang T; Pal U; Bao F; Gould LH; Fikrig E
    J Infect Dis; 2005 Apr; 191(7):1148-54. PubMed ID: 15747251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [West Nile virus: a new challenge?].
    Valero N
    Invest Clin; 2003 Sep; 44(3):175-7. PubMed ID: 14552056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience.
    Asnis DS; Conetta R; Teixeira AA; Waldman G; Sampson BA
    Clin Infect Dis; 2000 Mar; 30(3):413-8. PubMed ID: 10722421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. West Nile virus neutralization by US plasma-derived immunoglobulin products.
    Planitzer CB; Modrof J; Kreil TR
    J Infect Dis; 2007 Aug; 196(3):435-40. PubMed ID: 17597458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New avenues for therapeutic discovery against West Nile virus.
    Sinigaglia A; Peta E; Riccetti S; Barzon L
    Expert Opin Drug Discov; 2020 Mar; 15(3):333-348. PubMed ID: 32017639
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatal persistence of West Nile virus subtype Kunjin in the brains of flavivirus resistant mice.
    Shueb RH; Papadimitriou J; Urosevic N
    Virus Res; 2011 Feb; 155(2):455-61. PubMed ID: 21167228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virology, pathology, and clinical manifestations of West Nile virus disease.
    Hayes EB; Sejvar JJ; Zaki SR; Lanciotti RS; Bode AV; Campbell GL
    Emerg Infect Dis; 2005 Aug; 11(8):1174-9. PubMed ID: 16102303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The virology, epidemiology, and clinical impact of West Nile virus: a decade of advancements in research since its introduction into the Western Hemisphere.
    Murray KO; Walker C; Gould E
    Epidemiol Infect; 2011 Jun; 139(6):807-17. PubMed ID: 21342610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tregs control the development of symptomatic West Nile virus infection in humans and mice.
    Lanteri MC; O'Brien KM; Purtha WE; Cameron MJ; Lund JM; Owen RE; Heitman JW; Custer B; Hirschkorn DF; Tobler LH; Kiely N; Prince HE; Ndhlovu LC; Nixon DF; Kamel HT; Kelvin DJ; Busch MP; Rudensky AY; Diamond MS; Norris PJ
    J Clin Invest; 2009 Nov; 119(11):3266-77. PubMed ID: 19855131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ribavirin prophylaxis and therapy of experimental West Nile fever].
    Loginova SIa; Borisevich SV; Pashchenko IuA; Bondarev VP
    Antibiot Khimioter; 2009; 54(11-12):17-20. PubMed ID: 20583562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters.
    Zukor K; Wang H; Hurst BL; Siddharthan V; Van Wettere A; Pilowsky PM; Morrey JD
    J Neurovirol; 2017 Apr; 23(2):186-204. PubMed ID: 27761801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic.
    Lim JK; Louie CY; Glaser C; Jean C; Johnson B; Johnson H; McDermott DH; Murphy PM
    J Infect Dis; 2008 Jan; 197(2):262-5. PubMed ID: 18179388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.